- Easy to Learn, Easy to Employ
- Backed by Science, Powered by Data
- Receive an Objective Assessment in Seconds
- Non-Invasive, Sub-Millimeter Analysis
DermaSensor’s technology holds the promise of improving early detection of skin cancer by equipping primary care providers with a tool to better assess it.
David Leffell, M.D.
Chief, Section of Dermatologic Surgery
and Cutaneous Oncology, Yale School of Medicine
Scientific Advisory Board, DermaSensor
Make more informed decisions with DermaSensor's objective decision support tool.
99% of all skin cancer is curable if detected early. Our device has the potential to equip frontline providers to quickly and effectively check for all common types of skin cancer (melanoma, basal cell carcinoma, squamous cell carcinoma).